# Biologic Therapy in Pediatric JIA Uveitis

> **NCT05540743** · PHASE4 · UNKNOWN · sponsor: **Kasr El Aini Hospital** · enrollment: 250 (actual)

## Conditions studied

- Juvenile Idiopathic Arthritis Associated Uveitis

## Interventions

- **DRUG:** biologic DMARDs

## Key facts

- **NCT ID:** NCT05540743
- **Lead sponsor:** Kasr El Aini Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-01
- **Primary completion:** 2023-12
- **Final completion:** 2024-04
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2022-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05540743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05540743, "Biologic Therapy in Pediatric JIA Uveitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05540743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*